LEADER 01118nam2-2200373---450-
001 990005852880203316
005 20130603114949.0
010   $a978-3-7091-1368-4
035   $a000585288
035   $aUSA01000585288
035   $a(ALEPH)000585288USA01
035   $a000585288
100   $a20130603d2013----km-y0itay50------ba
101   $aeng
102   $aGB
105   $aa---||||001yy
200 1 $aSphingolipids$ebasic science and drug development$fErich Gulbins, Irina Petrache
210   $aNew York$cSpringer$d2013
215   $aVIII, 259 p.$cill.
225 2 $aHandbook of experimental pharmacology$v215
410  0$1001000320432$aHandbook of experimental pharmacology$v, 215
610 0 $aSfingolipidi
676   $a616.399
702  1$aGULBINS,$bErich
702  1$aPETRACHE,$bIrina
801  0$aIT$bsalbc$gISBD
912   $a990005852880203316
951   $a616.399 SPH 1$b5683 Farm.$c616.399$d00293039
959   $aBK
969   $aFAR
979   $aIANNONE$b90$c20130603$lUSA01$h1147
979   $aIANNONE$b90$c20130603$lUSA01$h1149
996   $aSphingolipids$91087179
997   $aUNISA